Description  Claims  Drawing  Cited references 

EP1961825A1   [0012] 
US20110150979A   [0013] 
US20100210738A   [0014] 
US20110130296A   [0015] 
WO2005046731A   [0035]  [0073]  [0230] 
WO2008098351A   [0035]  [0073] 
US2009048117A   [0035]  [0073] 
US067532   [0047] 
US181399   [0047] 
WO03020278A   [0114]  [0141]  [0197] 
WO03020721A   [0114]  [0141]  [0197] 
WO04000843A   [0114]  [0141]  [0197] 
WO0055126A   [0114]  [0141]  [0197] 
WO0149288A   [0114]  [0141]  [0197] 
US6740522B   [0115]  [0142]  [0198] 
US7411050B   [0115]  [0142]  [0198] 
US7097834B   [0115]  [0142]  [0198] 
US7364736B   [0115]  [0142]  [0198] 
WO2008142164A   [0116]  [0143]  [0199] 
US5176996A   [0211] 
US5264564A   [0211] 
US5256775A   [0211] 
WO8809810A   [0215] 
WO8910134A   [0215] 
WO2005026322A   [0225] 
WO2006135436A   [0226] 
WO2006012221A   [0226] 
US5093246A   [0232] 
US6274338B   [0238] 
US6287813B   [0240] 
US2004132086A   [0240] 
WO9738117A   [0240] 
WO8604920A   [0240] 
WO2004014888A   [0242] 
WO2009146546A   [0242] 
WO09049410A   [0242] 
WO08098351A   [0242] 
WO0359249A   [0242] 
WO2005063252A   [0243] 
US0230059W   [0243]  [0243]  [0243]  [0243] 
WO03027275A   [0243]  [0243]  [0243]  [0243] 
WO9509853A   [0243] 
WO07069090A   [0249] 
WO61621949A   [0338] 
EP1232139A   [0338] 
WO61724807A   [0338] 
WO61732175A   [0338] 

American Joint Committee on Cancer   [0003] 
Breast Cancer Research   [0008] 
Int J Cancer   [0009] 
Journal of Clinical Oncology   [0033] 
Construction of repeat-free fluorescence in situ hybridization probes   [0047] 
A new MAFia in cancer   [0049] 
Whole Genome Sequencing   [0051] 
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing   [0052] 
Molecular cloning: a Laboratory Manual   [0068] 
BLAST Manual   [0074] 
J. Mol. Biol.   [0074] 
Curr Protoc Cell Biol.   [0077] 
Statistics for Research   [0085] 
Statistics for Research   [0098] 
Everolimus in Postmenopausal Hormone-Receptor Positive Advanced Breast Cancer   [0111]  [0111]  [0194]  [0194] 
Updates of mTor inhibitors   [0111]  [0194] 
Regulation of Src Family Kinases in Human Cancers   [0112] 
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent survival signals   [0112]  [0195] 
Cyclooxygenase inhibitors- current status and future prospects   [0113]  [0196] 
American Association for Cancer Research Annual Meeting   [0114]  [0197] 
CHEMICAL ABSTRACTS   [0114] 
CHEMICAL ABSTRACTS   [0114] 
CHEMICAL ABSTRACTS   [0114] 
Nature   [0114]  [0141]  [0197]  [0235] 
mAbs   [0115]  [0142]  [0198] 
CHEMICAL ABSTRACTS   [0115]  [0142]  [0198] 
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells   [0118]  [0118]  [0145]  [0145]  [0201]  [0201] 
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5   [0118]  [0145]  [0201] 
Spiropiperidine CCR5 antagonists   [0118]  [0145]  [0201] 
HIV-1 entry inhibitors: an overview   [0118]  [0145]  [0201] 
American Association for Cancer Research Annual Meeting   [0141] 
Molecular Cloning: A Laboratory Manual   [0160] 
Current Protocols in Molecular Biology   [0160] 
A new MAFia in cancer   [0167] 
Regulation of Src Family Kinases in Human Cancers   [0195] 
BioTechniques   [0211] 
Cancer Res   [0211] 
Nature   [0213] 
Proc. Natl. Acad. Sci. U.S.A.   [0215] 
Proc. Natl. Acad. Sci.   [0215] 
Pharm. Res.   [0215] 
Proc. Natl. Acad. Sci. U.S.A.   [0216] 
Nature   [0216] 
Anticancer Drug Des.   [0220] 
Proc. Natl. Acad. Sci. USA.   [0225] 
Nat. Biotechnol.   [0225] 
BMC Biotechnol.   [0225] 
Proc. Natl. Acad. Sci. USA.   [0225] 
BMC Cell Biol.   [0225] 
Current Biology   [0232] 
Science   [0233] 
Oncogene   [0237] 
J. Biol.Chem.   [0237] 
Proc. Natl. Acad. Sci. USA   [0237] 
Mol. Cell. Biol.   [0237] 
Oncogene   [0237] 
Proc. Natl. Acad. Sci. USA   [0240] 
Science   [0240] 
Curr. Opin. Biotechnol.   [0240] 
Proc. Natl. Acad. Sci. USA   [0240] 
Proc. Natl. Acad. Sci. USA   [0240] 
Proc. Natl. Acad. Sci. USA   [0240] 
Nat. Med.   [0240] 
Science   [0243] 
Chem. Biol.   [0243] 
Eur. J. Biochem.   [0243] 
J. Biol. Chem.   [0243] 
J. Virol.   [0243] 
Int. J. Cancer   [0243] 
Eur. J. Biochem.   [0243] 
Bioorg. Med. Chem. Lett.   [0243] 
J. Med. Chem.   [0243] 
Bioorg. Med. Chem, Lett.   [0243] 
J. Med. Chem.   [0243] 
J. Med. Chem.   [0243]  [0243] 
Nature Structural Biology   [0243] 
Nat. Struct Biol.   [0243] 
Eur. J. Biochem.   [0243] 
Structure   [0243] 
Br. J. Cancer   [0243] 
Nat. Cell Biol.   [0243] 
Tetrahedron   [0243] 
Org. Process Res. Dev.   [0243] 
J. Med. Chem.   [0243] 
J. Med. Chem.   [0243] 
J. Med. Chem.   [0243] 
J. Med. Chem.   [0243] 
Med. Res. Rev.   [0243] 
Bioorg. Med. Chem. Lett.   [0243] 
J. Med. Chem.   [0243]  [0243] 
Science   [0243] 
Cancer Res.   [0243] 
Anticancer Res.   [0243] 
Cell Growth Differ.   [0243] 
Cancer Res.   [0243] 
Biochem. Biophys. Res. Commun.   [0243] 
Cancer Res.   [0243] 
J. Med. Chem.   [0243] 
Cancer Res.   [0243] 
Anticancer Res.   [0243] 
Pharmacol Ther.   [0243] 
Chemistry & Biology   [0243] 
Z. Naturforsch.   [0243] 
J. Med. Chem.   [0243] 
J. Med. Chem.   [0243] 
Oncogene   [0243] 
Tratado de Farmacia Galenica   [0247] 
Tratado de Farmacia Galénica   [0248] 
Remington's Pharmaceutical Sciences   [0248] 
DNA Cell Biol.   [0249] 
Trends Pharmacol. Sci   [0249] 
Trends Pharmacol. Sci.   [0249] 
Mol Therapy   [0249] 
Pharm. Res.   [0249] 
NCBI GEO: mining tens of millions of expression profiles-database and tools update   [0281] 
Bioconductor: Open software development for computa- tional biology and bioinformatics   [0281] 
Ann Oncol (   [0282] 
Genome Biology   [0312] 
Cancer Research   [0319] 
Nature Rev Cancer   [0319] 
Ann Oncol   [0330]